Gland Pharma shares up nearly 2% on USFDA approval for Eribulin Mesylate injection

Gland Pharma Share Price: The share price has gained 70 percent over the last 9 months.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *